Skip to main content
Top
Published in: Journal of Radiation Oncology 2/2017

01-06-2017 | Original Research

Radiotherapeutic care for brain metastases within the Veterans Health Administration (VHA): Practice patterns and guideline correlation

Authors: George A. Dawson, Maria D. Kelly, Sheetal Malhotra, Ruchika Gutt, Shruti Jolly, Drew Moghanaki, Michael Hagan, Helen Fosmire, Lori Hoffman-Hōgg, Stephen Lutz, Alice V. Cheuk, On behalf of the VHA National Palliative Radiotherapy Taskforce

Published in: Journal of Radiation Oncology | Issue 2/2017

Login to get access

Abstract

Objective

Brain metastases are common and complex to manage. Our goal was to determine practice patterns and adherence to guidelines among VHA Radiation Oncologists (ROs) regarding management of veterans with brain metastases.

Methods

A survey was e-mailed to all VHA ROs. Information queried included employment status, academic appointment, and years in practice. Number of patients with brain metastases seen per year, steroid usage/dosage, use of prognostic scores, and availability of stereotactic radiosurgery (SRS) and palliative care services was asked. ROs were presented with three scenarios involving patients with brain metastases and asked to choose optimal management.

Results

Sixty-four of 82 ROs responded to the questionnaire. All ROs had palliative care services at their facility. Prognostic scores were routinely calculated by 40.6% of ROs. Thirty-one percent of VA facilities performed SRS, and the remaining facilities referred patients out for this technology.
The responses to management of each of the clinical scenarios follows:
1.
(Uncontrolled cancer with hemiplegia, >10 brain metastases, poor Karnofsky Performance Score (KPS), and short life-expectancy (LE)): Sixty-six percent of respondents chose whole-brain radiation (WBRT) and 34% percent chose no intervention/supportive care or steroids only.
 
2.
(Controlled cancer with hemiplegia, 4–6 metastases, KPS 70, and LE >4 months): Ninety-five percent of ROs recommended WBRT.
 
3.
(Newly diagnosed cancer without symptoms, 2 brain lesions, KPS 90, and LE >6 months): Forty-four percent would recommend SRS alone while 35.9% would combine SRS with WBRT.
 

Conclusion

Veterans with brain metastases treated at VHA radiation oncology centers receive evidence-based care and have access to advanced technologies and palliative care services.
Literature
1.
go back to reference Patchell RA The management of brain metastases. Cancer Treatment Review 29(6):533–540 Patchell RA The management of brain metastases. Cancer Treatment Review 29(6):533–540
2.
go back to reference Ray S, Wang L, Martel MJ, Baser O (2013) J Clin Oncol 31(Suppl 31) abstract 2014 Ray S, Wang L, Martel MJ, Baser O (2013) J Clin Oncol 31(Suppl 31) abstract 2014
3.
go back to reference Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N (2005) Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Supportive care guidelines Group of Cancer Care Ontario’s program in evidence-based care. Cancer Treat Rev 31(4):256–273CrossRefPubMed Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N (2005) Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Supportive care guidelines Group of Cancer Care Ontario’s program in evidence-based care. Cancer Treat Rev 31(4):256–273CrossRefPubMed
4.
go back to reference Tsao MN, Rades D, Wirth A et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidenced-based guideline. Practical Radiation Oncology 2(3):210–225 Tsao MN, Rades D, Wirth A et al (2012) Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidenced-based guideline. Practical Radiation Oncology 2(3):210–225
5.
go back to reference Kress MS, Ramakrishna N, Makgoeng SB, Unger KR, Potosky AL (2012) Physician self-reported treatment of brain metastases according to patients’ clinical and demographic factors and physician practice setting. Radiat Oncol 7:188CrossRefPubMedPubMedCentral Kress MS, Ramakrishna N, Makgoeng SB, Unger KR, Potosky AL (2012) Physician self-reported treatment of brain metastases according to patients’ clinical and demographic factors and physician practice setting. Radiat Oncol 7:188CrossRefPubMedPubMedCentral
6.
go back to reference Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guideline for the management of brain metastases. Neurosurg Clin N Am 22:97–104CrossRefPubMed Bhangoo SS, Linskey ME, Kalkanis SN (2011) Evidence-based guideline for the management of brain metastases. Neurosurg Clin N Am 22:97–104CrossRefPubMed
7.
go back to reference Tsao MN, Rades D, Wirth A et al (2012) International practice survey on the management of brain metastases: third international consensus workshop on palliative radiotherapy and symptom control. Clin Oncol 24:e81–e92CrossRef Tsao MN, Rades D, Wirth A et al (2012) International practice survey on the management of brain metastases: third international consensus workshop on palliative radiotherapy and symptom control. Clin Oncol 24:e81–e92CrossRef
8.
go back to reference Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar MK, Mulvenna PM, QUARTZ Investigators (2013) Interim data from the Medical Research Council QUARTZ trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) 25(3):e23–e30CrossRef Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar MK, Mulvenna PM, QUARTZ Investigators (2013) Interim data from the Medical Research Council QUARTZ trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) 25(3):e23–e30CrossRef
9.
go back to reference Moghanaki D, Cheuk AV, Fosmire H, Anscher MS, Lutz ST, Hagan MP, Dawson GA (2014) Availability of single fraction palliative radiotherapy for cancer patients receiving end-of-life care within the veterans healthcare administration. J Palliat Med 17(11):1221–1225CrossRefPubMed Moghanaki D, Cheuk AV, Fosmire H, Anscher MS, Lutz ST, Hagan MP, Dawson GA (2014) Availability of single fraction palliative radiotherapy for cancer patients receiving end-of-life care within the veterans healthcare administration. J Palliat Med 17(11):1221–1225CrossRefPubMed
10.
go back to reference Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with and without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 363:1665–1672CrossRefPubMed Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with and without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 363:1665–1672CrossRefPubMed
11.
go back to reference Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. IntJ Radiat Oncol Biol Phys 45:427–434CrossRef Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. IntJ Radiat Oncol Biol Phys 45:427–434CrossRef
12.
go back to reference Young DF, Posner JB, Chu F, Nisce L (1974) Rapid-course radiation therapy of cerebral metastases: results and complications. Cancer 34:1069–1076CrossRefPubMed Young DF, Posner JB, Chu F, Nisce L (1974) Rapid-course radiation therapy of cerebral metastases: results and complications. Cancer 34:1069–1076CrossRefPubMed
13.
go back to reference Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215–1228CrossRefPubMed Sheline GE, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215–1228CrossRefPubMed
14.
go back to reference Choosing wisely American Society for Radiation Oncology: Five more things physicians and patients should question. Released September 15, 2014. ASC: 04/27/2016 Choosing wisely American Society for Radiation Oncology: Five more things physicians and patients should question. Released September 15, 2014. ASC: 04/27/2016
15.
go back to reference Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med 363:733–742CrossRefPubMed
16.
go back to reference Gaspar LE, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751CrossRefPubMed Gaspar LE, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751CrossRefPubMed
17.
go back to reference Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients. Int J Radiat Oncol Biol Phys 77:655–661CrossRefPubMed Sperduto PW, Chao ST, Sneed PK et al (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients. Int J Radiat Oncol Biol Phys 77:655–661CrossRefPubMed
18.
go back to reference Sperduto PW, Kased N, Roberge D et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425CrossRefPubMed Sperduto PW, Kased N, Roberge D et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425CrossRefPubMed
Metadata
Title
Radiotherapeutic care for brain metastases within the Veterans Health Administration (VHA): Practice patterns and guideline correlation
Authors
George A. Dawson
Maria D. Kelly
Sheetal Malhotra
Ruchika Gutt
Shruti Jolly
Drew Moghanaki
Michael Hagan
Helen Fosmire
Lori Hoffman-Hōgg
Stephen Lutz
Alice V. Cheuk
On behalf of the VHA National Palliative Radiotherapy Taskforce
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 2/2017
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-017-0310-y

Other articles of this Issue 2/2017

Journal of Radiation Oncology 2/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine